- Corporate Officers - N
- Nelsen Robert
Insider Trading History of Nelsen Robert
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nelsen Robert since 2015.
This trader's CIK number is 1219042.
At the time of last reporting, Nelsen Robert was the Director of Prime Medicine, Inc.. (stock ticker symbol PRME).
Also see all insider trading activities at Prime Medicine, Inc..
Note that in the past
NELSEN ROBERT also reported insider trading activities as an insider of the following companies:
Insider Activities at Prime Medicine, Inc. (PRME)
Insider Activities at Metsera, Inc. (MTSR)
Insider Activities at Sana Biotechnology, Inc. (SANA)
Insider Activities at Neumora Therapeutics, Inc. (NMRA)
Insider Activities at Denali Therapeutics Inc. (DNLI)
Insider Activities at 908 Devices Inc. (MASS)
Insider Activities at Vir Biotechnology, Inc. (VIR)
Insider Activities at Syros Pharmaceuticals, Inc. (SYRS)
Insider Activities at Karuna Therapeutics, Inc. (KRTX)
Insider Activities at Sienna Biopharmaceuticals, Inc. (SNNA)
Insider Activities at Twist Bioscience Corp (TWST)
Insider Activities at Pulmatrix, Inc. (PULM)
Insider Activities at Quanterix Corp (QTRX)
Insider Activities at Agios Pharmaceuticals, Inc. (AGIO)
Insider Activities at Adesto Technologies Corp (IOTS)
Insider Activities at Kythera Biopharmaceuticals Inc (KYTH)
Insider Activities at Bellerophon Therapeutics, Inc. (BLPH)
Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | NMRA | 507,064 | $5,952,206 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Syros Pharmaceuticals, Inc. (SYRS) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | SYRS | 0 | $0 | 395,086 | $2,932,670 | 0 | $0 |
2016 | SYRS | 400,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kythera Biopharmaceuticals Inc (KYTH) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | KYTH | 0 | $0 | 0 | $0 | 5,987 | $112,705 |
Yearly summary of insider trading at Quanterix Corp (QTRX) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | QTRX | 266,000 | $3,990,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Adesto Technologies Corp (IOTS) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | IOTS | 400,000 | $2,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vir Biotechnology, Inc. (VIR) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | VIR | 1,000,000 | $20,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sienna Biopharmaceuticals, Inc. (SNNA) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | SNNA | 6,497,400 | $16,243,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | AGIO | 0 | $0 | 378,446 | $18,771,167 | 0 | $0 |
Yearly summary of insider trading at Prime Medicine, Inc. (PRME) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | PRME | 3,030,300 | $9,999,990 | 0 | $0 | 0 | $0 |
2024 | PRME | 3,200,000 | $20,000,000 | 0 | $0 | 0 | $0 |
2022 | PRME | 800,000 | $13,600,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Karuna Therapeutics, Inc. (KRTX) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | KRTX | 200,000 | $3,200,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Metsera, Inc. (MTSR) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | MTSR | 2,222,222 | $39,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Denali Therapeutics Inc. (DNLI) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | DNLI | 0 | $0 | 0 | $0 | 3,253 | $0 |
Yearly summary of insider trading at Pulmatrix, Inc. (PULM) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | PULM | 1,150,000 | $0 | 0 | $0 | 0 | $0 |
2015 | PULM | 72,750 | $500,156 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at 908 Devices Inc. (MASS) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | MASS | 300,000 | $6,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sana Biotechnology, Inc. (SANA) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | SANA | 1,818,181 | $9,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Twist Bioscience Corp (TWST) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | TWST | 75,000 | $1,050,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bellerophon Therapeutics, Inc. (BLPH) by Nelsen Robert
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | BLPH | 212,666 | $2,551,992 | 0 | $0 | 0 | $0 |
Insider trading activities at 17 companies by Nelsen Robert:
1. Neumora Therapeutics, Inc. (NMRA)
2. Syros Pharmaceuticals, Inc. (SYRS)
3. Kythera Biopharmaceuticals Inc (KYTH)
4. Quanterix Corp (QTRX)
5. Adesto Technologies Corp (IOTS)
6. Vir Biotechnology, Inc. (VIR)
7. Sienna Biopharmaceuticals, Inc. (SNNA)
8. Agios Pharmaceuticals, Inc. (AGIO)
9. Prime Medicine, Inc. (PRME)
10. Karuna Therapeutics, Inc. (KRTX)
11. Metsera, Inc. (MTSR)
12. Denali Therapeutics Inc. (DNLI)
13. Pulmatrix, Inc. (PULM)
14. 908 Devices Inc. (MASS)
15. Sana Biotechnology, Inc. (SANA)
16. Twist Bioscience Corp (TWST)
17. Bellerophon Therapeutics, Inc. (BLPH)
Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-11-13 | NMRA | Buy | 31,653 | 11.75 | 371,922 |
2023-11-14 | NMRA | Buy | 3,357 | 11.98 | 40,216 |
2023-11-10 | NMRA | Buy | 17,275 | 11.56 | 199,699 |
2023-11-09 | NMRA | Buy | 31,079 | 10.53 | 327,261 |
2023-11-08 | NMRA | Buy | 92,251 | 11.29 | 1,041,052 |
2023-11-07 | NMRA | Buy | 30,192 | 11.50 | 347,208 |
2023-11-03 | NMRA | Buy | 22,420 | 11.38 | 255,139 |
2023-11-06 | NMRA | Buy | 43,082 | 11.55 | 497,597 |
2023-09-29 | NMRA | Buy | 34,560 | 13.98 | 483,148 |
2023-09-28 | NMRA | Buy | 41,951 | 13.38 | 561,094 |
2023-09-26 | NMRA | Buy | 34,000 | 11.73 | 398,820 |
2023-09-27 | NMRA | Buy | 24,504 | 12.31 | 301,644 |
2023-09-22 | NMRA | Buy | 40,000 | 11.14 | 445,600 |
2023-09-25 | NMRA | Buy | 60,740 | 11.22 | 681,806 |
Table 2. Insider trading of Syros Pharmaceuticals, Inc. (SYRS) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-15 | SYRS | Sale | 2,700 | 8.27 | 22,315 |
2019-07-16 | SYRS | Sale | 25,779 | 7.81 | 201,282 |
2019-07-17 | SYRS | Sale | 34,521 | 7.70 | 265,673 |
2019-03-12 | SYRS | Sale | 40,092 | 7.37 | 295,357 |
2019-03-13 | SYRS | Sale | 84,411 | 8.04 | 678,917 |
2019-03-14 | SYRS | Sale | 43,000 | 8.15 | 350,450 |
2019-03-11 | SYRS | Sale | 44,878 | 6.49 | 291,347 |
2019-03-07 | SYRS | Sale | 35,209 | 6.87 | 242,026 |
2019-03-08 | SYRS | Sale | 84,496 | 6.93 | 585,303 |
2016-07-06 | SYRS | Buy | 400,000 | 12.50 | 5,000,000 |
Table 3. Insider trading of Kythera Biopharmaceuticals Inc (KYTH) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-03-24 | KYTH | Option Ex | 5,987 | 18.82 | 112,705 |
Table 4. Insider trading of Quanterix Corp (QTRX) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-12-11 | QTRX | Buy | 266,000 | 15.00 | 3,990,000 |
Table 5. Insider trading of Adesto Technologies Corp (IOTS) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-10-26 | IOTS | Buy | 400,000 | 5.00 | 2,000,000 |
Table 6. Insider trading of Vir Biotechnology, Inc. (VIR) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-10-16 | VIR | Buy | 1,000,000 | 20.00 | 20,000,000 |
Table 7. Insider trading of Sienna Biopharmaceuticals, Inc. (SNNA) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-02-22 | SNNA | Buy | 2,165,800 | 2.50 | 5,414,500 |
2019-02-22 | SNNA | Buy | 2,165,800 | 2.50 | 5,414,500 |
2019-02-22 | SNNA | Buy | 2,165,800 | 2.50 | 5,414,500 |
Table 8. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-02-27 | AGIO | Sale | 195,223 | 49.26 | 9,616,294 |
2017-02-28 | AGIO | Sale | 47,859 | 49.82 | 2,384,431 |
2017-02-23 | AGIO | Sale | 50,996 | 48.24 | 2,459,894 |
2017-02-22 | AGIO | Sale | 47,938 | 50.12 | 2,402,892 |
2017-02-21 | AGIO | Sale | 36,430 | 52.37 | 1,907,656 |
Table 9. Insider trading of Prime Medicine, Inc. (PRME) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-01 | PRME | Buy | 3,030,300 | 3.30 | 9,999,990 |
2024-02-15 | PRME | Buy | 3,200,000 | 6.25 | 20,000,000 |
2022-10-24 | PRME | Buy | 800,000 | 17.00 | 13,600,000 |
Table 10. Insider trading of Karuna Therapeutics, Inc. (KRTX) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-02 | KRTX | Buy | 200,000 | 16.00 | 3,200,000 |
Table 11. Insider trading of Metsera, Inc. (MTSR) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-03 | MTSR | Buy | 2,222,222 | 18.00 | 39,999,996 |
Table 12. Insider trading of Denali Therapeutics Inc. (DNLI) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-06-01 | DNLI | Option Ex | 3,253 | .00 | 0 |
Table 13. Insider trading of Pulmatrix, Inc. (PULM) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-04-03 | PULM | Buy | 1,150,000 | .00 | 0 |
2015-06-16 | PULM | Buy | 72,750 | 6.88 | 500,156 |
Table 14. Insider trading of 908 Devices Inc. (MASS) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-12-22 | MASS | Buy | 300,000 | 20.00 | 6,000,000 |
Table 15. Insider trading of Sana Biotechnology, Inc. (SANA) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-02-08 | SANA | Buy | 1,818,181 | 5.50 | 9,999,995 |
Table 16. Insider trading of Twist Bioscience Corp (TWST) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-11-02 | TWST | Buy | 75,000 | 14.00 | 1,050,000 |
Table 17. Insider trading of Bellerophon Therapeutics, Inc. (BLPH) by Nelsen Robert
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-02-19 | BLPH | Buy | 212,666 | 12.00 | 2,551,992 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nelsen Robert
(Director of Prime Medicine, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.